Search

A two-arm molecule can effectively deplete cancer-protecting cells inside tumors, allowing the immune system to fight off tumors without becoming overactive.

The PGA of America and Omni Hotels & Resorts today announced a new six-year partnership with UT Southwestern Medical Center, naming the hospital as the “Official Healthcare Partner of PGA Frisco.” The relationship will begin in 2023, to coincide with the official opening of PGA Frisco and Omni PGA

More than 200 UT Southwestern medical students matched to more than 80 programs across the nation, including Harvard, Yale, and Johns Hopkins, as well as a dozen medical programs across Texas.

To meet growing demand for primary and preventive health care in Fort Worth, Tarrant and surrounding counties, UT Southwestern Medical Center has launched a new primary care clinic in the UT Southwestern Monty and Tex Moncrief Medical Center at Fort Worth.

Diagnosing heart attacks after heart surgery remains difficult due to shortcomings of current diagnostic tools when applied to postoperative patients.

Cognitive decline is the biggest factor in determining how long patients with Alzheimer’s disease will live after being diagnosed, according to a new study from researchers at UT Southwestern.

Researchers at UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center are developing an innovative interface to make the wealth of genomics data from next-generation sequencing visible and actionable in real time for clinicians and researchers.

Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer

Researchers at UT Southwestern have developed a first-of-its-kind ultrasound-guided cancer immunotherapy platform that delivers immune-stimulating agents to cells for the development of systemic anti-tumor immunity.

A multicenter study performed by a large international consortium that includes UT Southwestern has outlined a set of risk factors and outcomes for patients with autoimmune hepatitis (AIH) that recurs after liver transplantation.